UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2024

EATON CORPORATION plc
 (Exact name of registrant as specified in its charter)
 
Ireland
 
000-54863
  98-1059235
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)

 
 Eaton House, 30 Pembroke Road, Dublin 4, Ireland
 
D04 Y0C2
(Address of principal executive offices)
 
(Zip Code)
 
 
+353 1637 2900
 
 
(Registrant’s telephone number, including area code)
 
 
 
 
Not applicable
 
 
(Former name or former address, if changed since last report.)
 
 
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Ordinary shares ($0.01 par value)   ETN
 
NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □



Item
5.07 Submission of Matters to a Vote of Security Holders.

(a)(b) At the Annual General Meeting of Shareholders of the Company held on April 24, 2024, the items listed below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in the Company’s Proxy Statement for the 2024 Annual General Meeting of Shareholders. Each of the items was approved by the shareholders. The voting results for each proposal are set forth below.

Item 1 – Electing the nine director nominees named in the proxy statement.

Each of the following individuals was elected as a director, based on the voting results shown below, to serve until the 2025 Annual General Meeting of Shareholders or until his or her successor is duly elected and qualified:

Director

For
 
Against
 
Abstain
 
Broker Non-Votes
                 
Craig Arnold

299,100,890
 
22,856,644
 
1,204,003
 
37,740,519
                 
Silvio Napoli

316,936,638
 
  5,290,389
 
   934,510
 
37,740,519
                 
Gregory R. Page

290,714,807
 
31,477,878
 
968,852
 
37,740,519
                 
Sandra Pianalto

320,814,934
 
  1,479,770
 
   866,833
 
37,740,519
                 
Robert V. Pragada

316,184,253
 
  6,061,395
 
   915,889
 
37,740,519
                 
Lori J. Ryerkerk

301,629,170
 
  20,635,647
 
   896,720
 
37,740,519
                 
Gerald B. Smith

305,813,975
 
  16,450,177
 
   897,385
 
37,740,519
                 
Dorothy C. Thompson

316,485,131
 
  5,768,924
 
   907,482
 
37,740,519
                 
Darryl L. Wilson

317,823,559
 
  4,443,957
 
   894,021
 
37,740,519

Item 2 – Appointment of Ernst & Young LLP as independent auditor for 2024 and authorizing the Audit Committee of the Board of Directors to set its remuneration.

For
 
Against
 
Abstain
338,500,748
 
21,604,164
 
797,144

Item 3 – Advisory approval of the Company’s executive compensation (“Say on Pay Vote”).

For
 
Against
 
Abstain
 
Broker Non-Votes
296,746,406
 
25,058,023
 
1,357,108
 
37,740,519


Item 4 – Grant of Board authority to issue shares under Irish law.

For
 
Against
 
Abstain
349,190,062
 
10,458,122
 
1,253,872

 
Item 5 - Grant of Board authority to opt-out of pre-emption rights under Irish law.

For
 
Against
 
Abstain
335,639,933
 
23,501,849
 
1,760,274
 
Item 6 – Authorization to the Company and or any subsidiary of the Company to make overseas market purchases of Company shares.

For
 
Against
 
Abstain
351,765,272
 
7,308,622
 
1,828,162


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Eaton Corporation plc




Date: April 24, 2024
/s/ Taras G. Szmagala
 
Taras G. Szmagala,
Executive Vice President and Chief Legal Officer

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: Financial_Report.xlsx

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ef20027848_8k_htm.xml